Baxter International Inc. BAX
NYSE · United States · Health Technology
$24.00+0.52 (+2.21%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Baxter International (BAX) has drawn fresh attention after publishing its 2026 Connected Hospital Report, spotlighting how U.S. hospitals are using technology maturity benchmarks to pursue operational efficiency, workflow automation, and data integration priorities. Baxter International’s recent Connected Hospital Report lands after a mixed run in the stock, with the share price up 20.41% year to date and 8.25% over 90 days but down 10.14% over the past month. Total shareholder return sits at...
DEERFIELD, Ill., September 30, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the release of its 2026 Connected Hospital Report, offering new insights into how hospitals across the United States are leveraging technology investments to drive clinical and operational outcomes.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.